CanSino's COVID-19 vaccine approved for military use in China - (Nikkei Asian Review via NewsPoints Desk)

  • China's military has been cleared to use a COVID-19 vaccine candidate developed by its research unit and CanSino Biologics after clinical trials indicated that it was safe and showed some efficacy, as reported in Nikkei Asian Review.

  • The Ad5-nCoV is one of China's eight vaccine candidates approved for human trials at home and abroad for COVID-19. The experimental vaccine also won approval for clinical testing in Canada.

  • China's Central Military Commission approved use of the vaccine by the military on June 25 for a period of one year, CanSino said in a filing.

  • "The Ad5-nCoV is currently limited to military use only and its use cannot be expanded to a broader vaccination range without the approval of the Logistics Support Department," CanSino said.

To read more NewsPoints articles, click here.

Reference Articles